Navigate Questions About the Medicare GLP-1 Bridge

July 2026

You’ll see even more patients admitted on a GLP-1 agonist for obesity due to Medicare’s GLP-1 Bridge program launching July 1, 2026.

Plus many patients may be unaware of this new program. Be ready to answer questions from patients, prescribers, family and friends, etc.

What is the GLP-1 Bridge? It’s a program from Centers for Medicare & Medicaid Services (CMS) that allows eligible patients with Medicare Part D to get certain GLP-1 drugs for weight management for a $50 copay.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Surgery Avoid Mix-Ups with New Room Temperature Rocuronium
Stroke Timely Meds Are Key to Survival for Ischemic Strokes
Lyme Disease Brush Up on Tick Bites and Lyme Disease
Antithrombotics Help Optimize Antithrombotic Stewardship in Your Hospital
GLP-1 Agonists Navigate Questions About the Medicare GLP-1 Bridge
Practice Don’t Let Return-to-Stocks Become “Return-to-Risk”
Rumor vs Truth Listen for Common Claims About Laxatives and Constipation
NatMed Spotlight Put Claims About Methylene Blue in Perspective

Navigate Questions About the Medicare GLP-1 Bridge

Practical advice for a better career, with unlimited access to CE

Table of Contents